Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Ibexx who wrote (2564)	5/18/1998 2:28:00 PM
From: Jim Lamb	Read Replies (2) \| Respond to of 9523

Ibexx,I guess most molecules like it are simple to make for a good chemist with the chemicals and the formula in hand.Pfe still holds the patent to the molecule and that is what needs to be protected. Amgen has been through this "process" issue with Epogen a couple of times and always won in the courts. Most people in developed countries will still want the real thing.IMHO Jim